Lv410
512 积分 2022-04-14 加入
Autoimmune mechanisms and inflammation in obesity-associated type 2 diabetes, atherosclerosis, and non-alcoholic fatty liver disease
1小时前
已完结
Two Phase 3 Trials of Baricitinib for Alopecia Areata
20小时前
已完结
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
21小时前
已完结
Loss of efficacy of secukinumab for psoriasis at 24 to 32 weeks
1天前
已完结
TYK2 as a Therapeutic Target in the Treatment of Autoimmune and Inflammatory Diseases
3天前
已完结
New anti-IL-23 drugs raise hopes for psoriasis plaque clearance
3天前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
3天前
已完结
Diagnostic value and safety of endomyocardial biopsy in selected patients with heart failure
5天前
已完结
The molecular pharmacology of glucagon agonists in diabetes and obesity
6天前
已完结
Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD
6天前
已完结
皖公网安备34019202002308
